首页 > 最新文献

Schizophrenia Research最新文献

英文 中文
Dynamic effective connectivity in the cerebellar dorsal dentate nucleus and the cerebrum, cognitive impairment, and clinical correlates in patients with schizophrenia 精神分裂症患者小脑背侧齿状核与大脑的动态有效连接、认知障碍及临床相关性。
IF 3.6 2区 医学 Q1 PSYCHIATRY Pub Date : 2024-09-01 DOI: 10.1016/j.schres.2024.05.003

Background

Schizophrenia (SZ) is characterized by disconnected cerebral networks. Recent studies have shown that functional connectivity between the cerebellar dorsal dentate nucleus (dDN) and cerebrum is correlated with psychotic symptoms, and processing speed in SZ patients. Dynamic effective connectivity (dEC) is a reliable indicator of brain functional status. However, the dEC between the dDN and cerebrum in patients with SZ remains largely unknown.

Methods

Resting-state functional MRI data, symptom severity, and cognitive performance were collected from 74 SZ patients and 53 healthy controls (HC). Granger causality analysis and sliding time window methods were used to calculate dDN-based dEC maps for all subjects, and k-means clustering was performed to obtain several dEC states. Finally, between-group differences in dynamic effective connectivity variability (dECV) and clinical correlations were obtained using two-sample t-tests and correlation analysis.

Results

We detected four dEC states from the cerebrum to the right dDN (IN states) and three dEC states from the right dDN to the cerebrum (OUT states), with SZ group having fewer transitions in the OUT states. SZ group had increased dECV from the right dDN to the right middle frontal gyrus (MFG) and left lingual gyrus (LG). Correlations were found between the dECV from the right dDN to the right MFG and symptom severity and between the dECV from the right dDN to the left LG and working memory performance.

Conclusions

This study reveals a dynamic causal relationship between cerebellar dDN and the cerebrum in SZ and provides new evidence for the involvement of cerebellar neural circuits in neurocognitive functions in SZ.

背景:精神分裂症(SZ)的特征是大脑网络脱节。最近的研究表明,小脑背侧齿状核(dDN)和大脑之间的功能连接与精神分裂症患者的精神症状和处理速度相关。动态有效连接(dEC)是大脑功能状态的可靠指标。然而,SZ患者dDN与大脑之间的动态有效连接性在很大程度上仍不为人所知:方法:收集了74名SZ患者和53名健康对照组(HC)的静息态功能磁共振成像数据、症状严重程度和认知表现。采用格兰杰因果关系分析法和滑动时间窗法计算所有受试者的基于dDN的dEC图,并进行k-means聚类以获得几种dEC状态。最后,利用双样本 t 检验和相关性分析得出了动态有效连接变异性(dECV)的组间差异和临床相关性:结果:我们检测到从大脑到右侧dDN的四个dEC状态(IN状态)和从右侧dDN到大脑的三个dEC状态(OUT状态),SZ组在OUT状态中的转换较少。SZ 组从右侧 dDN 到右侧额叶中回(MFG)和左侧舌回(LG)的 dECV 增加。研究发现,右侧dDN至右侧MFG的dECV与症状严重程度相关,右侧dDN至左侧LG的dECV与工作记忆表现相关:这项研究揭示了SZ患者小脑dDN与大脑之间的动态因果关系,为小脑神经回路参与SZ患者的神经认知功能提供了新的证据。
{"title":"Dynamic effective connectivity in the cerebellar dorsal dentate nucleus and the cerebrum, cognitive impairment, and clinical correlates in patients with schizophrenia","authors":"","doi":"10.1016/j.schres.2024.05.003","DOIUrl":"10.1016/j.schres.2024.05.003","url":null,"abstract":"<div><h3>Background</h3><p><span>Schizophrenia (SZ) is characterized by disconnected cerebral networks. Recent studies have shown that </span>functional connectivity<span> between the cerebellar dorsal dentate nucleus<span> (dDN) and cerebrum is correlated with psychotic symptoms, and processing speed in SZ patients. Dynamic effective connectivity (dEC) is a reliable indicator of brain functional status. However, the dEC between the dDN and cerebrum in patients with SZ remains largely unknown.</span></span></p></div><div><h3>Methods</h3><p><span>Resting-state functional MRI data, symptom severity, and cognitive performance were collected from 74 SZ patients and 53 healthy controls (HC). Granger causality analysis and sliding time window methods were used to calculate dDN-based dEC maps for all subjects, and k-means clustering was performed to obtain several dEC states. Finally, between-group differences in dynamic effective connectivity variability (dECV) and clinical correlations were obtained using two-sample </span><em>t</em>-tests and correlation analysis.</p></div><div><h3>Results</h3><p><span>We detected four dEC states from the cerebrum to the right dDN (IN states) and three dEC states from the right dDN to the cerebrum (OUT states), with SZ group having fewer transitions in the OUT states. SZ group had increased dECV from the right dDN to the right middle frontal gyrus (MFG) and left </span>lingual gyrus (LG). Correlations were found between the dECV from the right dDN to the right MFG and symptom severity and between the dECV from the right dDN to the left LG and working memory performance.</p></div><div><h3>Conclusions</h3><p>This study reveals a dynamic causal relationship between cerebellar dDN and the cerebrum in SZ and provides new evidence for the involvement of cerebellar neural circuits in neurocognitive functions in SZ.</p></div>","PeriodicalId":21417,"journal":{"name":"Schizophrenia Research","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140904791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disentangling negative and positive symptoms in schizophrenia and autism spectrum disorder. 区分精神分裂症和自闭症谱系障碍的阴性症状和阳性症状。
IF 3.6 2区 医学 Q1 PSYCHIATRY Pub Date : 2024-09-01 Epub Date: 2024-07-14 DOI: 10.1016/j.schres.2024.07.002
Silvia Corbera, Bruce E Wexler, Morris D Bell, Brian Pittman, Kevin Pelphrey, Godfrey Pearlson, Michal Assaf

Autism spectrum disorder (ASD) and schizophrenia (SZ) share traits, especially in social skills and negative symptoms, and to a lesser degree positive symptoms. Differential diagnosis can be challenging and discerning expressive and experiential negative symptoms may provide knowledge with potential diagnostic and functional relevance that can guide treatment. Two exploratory factor analyses (EFA) were conducted to reveal the underlying dimensions of negative and positive symptoms using the Positive and Negative Syndrome Scale (PANSS), the Scale for the Assessment of Positive Symptoms & Negative Symptoms (SAPS/SANS) and the Autism Diagnostic Observation Schedule-Generic (ADOS-G). Three factors emerged from the negative symptom EFA (70.5 % variance): NF1) Expressive Negative; NF2) Experiential Negative; and NF3) Preoccupation, Absorption & Expressive Affective Flattening. Three positive factors emerged (68.6 % variance): PF1) Hallucinations-Delusions; PF2) Grandiosity; and PF3) Thought Disorder-ADOS positive Symptoms. SZ showed higher PF1 scores, and ASD had higher PF3 scores. No differences between groups were observed in the negative factors. Across groups, all negative factors were inversely associated with quality of life. Only NF1 and NF2 and PF1 were detrimentally related to social functioning. A discriminant function analysis using all factors classified correctly 84.4 % of participants, with PF1, NF1 followed by NF2 being the best predictors of diagnosis. Expressive negative followed by Experiential negative symptoms are of diagnostic value independent of and beyond SZ-related positive symptoms and are related with detrimental functioning. Findings confirm the need to distinctively target negative symptoms, and specific SZ-related and ASD-related positive symptoms, and especially the use of several assessment tools for diagnostic classification.

自闭症谱系障碍(ASD)和精神分裂症(SZ)具有共同的特征,尤其是在社交技能和阴性症状方面,其阳性症状的程度较轻。鉴别诊断具有挑战性,而辨别表达性和体验性阴性症状可以提供潜在的诊断和功能相关知识,从而指导治疗。我们使用阳性和阴性综合征量表(PANSS)、阳性症状和阴性症状评估量表(SAPS/SANS)以及通用自闭症诊断观察表(ADOS-G)进行了两次探索性因子分析(EFA),以揭示阴性和阳性症状的基本维度。在负性症状 EFA(方差占 70.5%)中出现了三个因子:NF1)表达性消极;NF2)体验性消极;NF3)专注、吸收和表达性情感平淡。出现了三个积极因素(68.6 % 的方差):PF1)幻觉-妄想;PF2)自大;PF3)思维障碍-ADOS 阳性症状。SZ 的 PF1 分数较高,而 ASD 的 PF3 分数较高。各组之间在消极因素方面没有发现差异。在所有组别中,所有消极因素都与生活质量成反比。只有 NF1 和 NF2 以及 PF1 与社会功能呈负相关。利用所有因素进行的判别函数分析正确地对 84.4% 的参与者进行了分类,其中 PF1、NF1 和 NF2 是预测诊断的最佳因素。表现性阴性症状和体验性阴性症状具有独立于 SZ 相关阳性症状之外的诊断价值,并与有害功能相关。研究结果证实,有必要针对不同的阴性症状、与 SZ 相关的特定阳性症状和与 ASD 相关的阳性症状进行诊断,尤其是使用多种评估工具进行诊断分类。
{"title":"Disentangling negative and positive symptoms in schizophrenia and autism spectrum disorder.","authors":"Silvia Corbera, Bruce E Wexler, Morris D Bell, Brian Pittman, Kevin Pelphrey, Godfrey Pearlson, Michal Assaf","doi":"10.1016/j.schres.2024.07.002","DOIUrl":"10.1016/j.schres.2024.07.002","url":null,"abstract":"<p><p>Autism spectrum disorder (ASD) and schizophrenia (SZ) share traits, especially in social skills and negative symptoms, and to a lesser degree positive symptoms. Differential diagnosis can be challenging and discerning expressive and experiential negative symptoms may provide knowledge with potential diagnostic and functional relevance that can guide treatment. Two exploratory factor analyses (EFA) were conducted to reveal the underlying dimensions of negative and positive symptoms using the Positive and Negative Syndrome Scale (PANSS), the Scale for the Assessment of Positive Symptoms & Negative Symptoms (SAPS/SANS) and the Autism Diagnostic Observation Schedule-Generic (ADOS-G). Three factors emerged from the negative symptom EFA (70.5 % variance): NF1) Expressive Negative; NF2) Experiential Negative; and NF3) Preoccupation, Absorption & Expressive Affective Flattening. Three positive factors emerged (68.6 % variance): PF1) Hallucinations-Delusions; PF2) Grandiosity; and PF3) Thought Disorder-ADOS positive Symptoms. SZ showed higher PF1 scores, and ASD had higher PF3 scores. No differences between groups were observed in the negative factors. Across groups, all negative factors were inversely associated with quality of life. Only NF1 and NF2 and PF1 were detrimentally related to social functioning. A discriminant function analysis using all factors classified correctly 84.4 % of participants, with PF1, NF1 followed by NF2 being the best predictors of diagnosis. Expressive negative followed by Experiential negative symptoms are of diagnostic value independent of and beyond SZ-related positive symptoms and are related with detrimental functioning. Findings confirm the need to distinctively target negative symptoms, and specific SZ-related and ASD-related positive symptoms, and especially the use of several assessment tools for diagnostic classification.</p>","PeriodicalId":21417,"journal":{"name":"Schizophrenia Research","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11384336/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141604083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relations between changes in safety behavior, paranoid ideations, cognitive biases, and clinical characteristics of patients with a psychotic disorder over time 精神病患者的安全行为、偏执想法、认知偏差和临床特征随时间变化的关系
IF 3.6 2区 医学 Q1 PSYCHIATRY Pub Date : 2024-08-29 DOI: 10.1016/j.schres.2024.08.005

Background

Safety behaviors, both positive (maladaptive coping behavior) and negative (avoidance behavior), are used by people with paranoid delusions to avoid perceived threats. Safety behaviors contribute to the persistence of paranoid delusions by preventing disconfirmation of threat beliefs and may influence other psychiatric symptoms. This study investigated how changes in safety behaviors are related to changes in paranoid ideation, social anxiety, depression, cognitive biases and self-esteem over time.

Methods

This study included 116 patients diagnosed with a psychotic disorder (DSM-IV) and at least moderate levels of paranoid ideations (GTPS >40).The data were collected as part of a multi-center randomized controlled trial where patients were randomized to VR-CBT (n = 58) or treatment as usual (TAU; n = 58). Assessments were completed at baseline (T0), after three months (T3) and after six months (T6). For all variables, change scores between T0 and T3 and T3 and T6 were calculated and Pearson correlations between change scores were computed.

Results

A decrease in total safety behavior was related to diminished paranoid ideation, social anxiety, and depression. No significant temporal associations were found between changes in safety behavior and changes in cognitive biases and self-esteem. Similar but less robust results were found for respectively negative safety behavior and positive safety behavior.

Conclusion

Dropping safety behavior can be specifically targeted in behavioral interventions. Whereas there appears to be a relation with reduction in anxiety, paranoia, and depressive symptoms, changes in safety behavior do not seem to align with changes in cognitive thinking processes.

背景妄想症患者会通过积极(适应不良的应对行为)和消极(回避行为)的安全行为来避免感知到的威胁。安全行为通过防止威胁信念不被证实而导致妄想症持续存在,并可能影响其他精神症状。本研究调查了安全行为的变化与妄想症、社交焦虑、抑郁、认知偏差和自尊随时间推移的变化之间的关系。本研究纳入了116名被诊断患有精神病性障碍(DSM-IV)和至少中度妄想症(GTPS>40)的患者。评估分别在基线(T0)、三个月后(T3)和六个月后(T6)完成。计算了所有变量在 T0 和 T3 之间以及 T3 和 T6 之间的变化分数,并计算了变化分数之间的皮尔逊相关性。在安全行为的变化与认知偏差和自尊的变化之间没有发现明显的时间关联。在消极安全行为和积极安全行为方面也发现了类似的结果,但不太稳健。虽然安全行为的变化似乎与焦虑、偏执和抑郁症状的减少有关,但安全行为的变化似乎与认知思维过程的变化并不一致。
{"title":"Relations between changes in safety behavior, paranoid ideations, cognitive biases, and clinical characteristics of patients with a psychotic disorder over time","authors":"","doi":"10.1016/j.schres.2024.08.005","DOIUrl":"10.1016/j.schres.2024.08.005","url":null,"abstract":"<div><h3>Background</h3><p>Safety behaviors, both positive (maladaptive coping behavior) and negative (avoidance behavior), are used by people with paranoid delusions to avoid perceived threats. Safety behaviors contribute to the persistence of paranoid delusions by preventing disconfirmation of threat beliefs and may influence other psychiatric symptoms. This study investigated how changes in safety behaviors are related to changes in paranoid ideation, social anxiety, depression, cognitive biases and self-esteem over time.</p></div><div><h3>Methods</h3><p>This study included 116 patients diagnosed with a psychotic disorder (DSM-IV) and at least moderate levels of paranoid ideations (GTPS &gt;40).The data were collected as part of a multi-center randomized controlled trial where patients were randomized to VR-CBT (<em>n</em> = 58) or treatment as usual (TAU; n = 58). Assessments were completed at baseline (T0), after three months (T3) and after six months (T6). For all variables, change scores between T0 and T3 and T3 and T6 were calculated and Pearson correlations between change scores were computed.</p></div><div><h3>Results</h3><p>A decrease in total safety behavior was related to diminished paranoid ideation, social anxiety, and depression. No significant temporal associations were found between changes in safety behavior and changes in cognitive biases and self-esteem. Similar but less robust results were found for respectively negative safety behavior and positive safety behavior.</p></div><div><h3>Conclusion</h3><p>Dropping safety behavior can be specifically targeted in behavioral interventions. Whereas there appears to be a relation with reduction in anxiety, paranoia, and depressive symptoms, changes in safety behavior do not seem to align with changes in cognitive thinking processes.</p></div>","PeriodicalId":21417,"journal":{"name":"Schizophrenia Research","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S092099642400375X/pdfft?md5=733298237bb59048dc6adc93f38bc8bf&pid=1-s2.0-S092099642400375X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142099634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The timing and severity of clozapine-associated neutropenia in the US: Is the risk overstated? 美国氯氮平相关中性粒细胞减少症的发生时间和严重程度:风险是否被夸大了?
IF 3.6 2区 医学 Q1 PSYCHIATRY Pub Date : 2024-08-29 DOI: 10.1016/j.schres.2024.08.018

Background

Concern about clozapine-associated neutropenia contributes to clozapine's underutilization and racial disparities in access. People with African ancestry are more likely to have lower normative absolute neutrophil counts (ANC), associated with the Duffy null genetic polymorphism. Recent data on clozapine-associated neutropenia in the US are lacking.

Methods

Patients prescribed clozapine in the Johns Hopkins Medicine electronic medical record (EMR) between 2013 and 2023 were identified. Duffy null Associated Neutrophil Count (DANC) was assigned if there were two ANC's < 2000 cells/μL, >30 days apart, before starting clozapine. Rates of neutropenia, timing of first neutropenia, and demographic differences were explored.

Results

974 received clozapine and had ANC's available, with 63.9 % male, 51.1 % White, and 39 % Black. 287 were presumed to start clozapine during the study period, and were 62.4 % male, 46 % White, and 44.9 % Black. No patients developed severe neutropenia. 59 (6.1 %) developed mild or moderate neutropenia. 19 (6.6 %) new starts had presumed DANC, and none developed neutropenia. 11 of 16 presumed new starts who developed neutropenia did so within eight months. No demographic differences were found between groups for presumed new starts. For non-new starts, where DANC assignment was not possible, Black patients were more likely than White patients to develop neutropenia (OR 3.48, 95 % CI [1.65, 7.73]).

Discussion

To our knowledge, this is the first observational study of clozapine-associated neutropenia in the US in the past decade, and it includes a substantial proportion of Black patients. ANC monitoring requirements may be too strict, contributing to clozapine underutilization.

背景对氯氮平相关中性粒细胞减少症的担忧导致了氯氮平的使用不足和使用中的种族差异。非洲裔患者的中性粒细胞绝对计数(ANC)更有可能低于正常水平,这与 Duffy null 基因多态性有关。方法确定了2013年至2023年期间约翰霍普金斯医学院电子病历(EMR)中开具氯氮平处方的患者。如果在开始使用氯氮平之前,ANC 两次达到 <2000 cells/μL, >相隔 30 天,则计算 Duffy null 相关中性粒细胞计数 (DANC)。研究人员对中性粒细胞减少率、首次中性粒细胞减少的时间以及人口统计学差异进行了探讨。结果 有974人接受了氯氮平治疗并获得了ANC,其中男性占63.9%,白人占51.1%,黑人占39%。287名患者被推测在研究期间开始服用氯氮平,其中62.4%为男性,46%为白人,44.9%为黑人。没有患者出现严重的中性粒细胞减少症。59人(6.1%)出现轻度或中度中性粒细胞减少症。19名(6.6%)新入组患者推测患有 DANC,但无一人出现中性粒细胞减少症。16 名推测的新患者中有 11 人在 8 个月内出现中性粒细胞减少症。推测的新发病例组间未发现人口统计学差异。据我们所知,这是美国近十年来首次对氯氮平相关中性粒细胞减少症进行的观察性研究,其中包括了相当一部分黑人患者。ANC监测要求可能过于严格,导致氯氮平使用不足。
{"title":"The timing and severity of clozapine-associated neutropenia in the US: Is the risk overstated?","authors":"","doi":"10.1016/j.schres.2024.08.018","DOIUrl":"10.1016/j.schres.2024.08.018","url":null,"abstract":"<div><h3>Background</h3><p>Concern about clozapine-associated neutropenia contributes to clozapine's underutilization and racial disparities in access. People with African ancestry are more likely to have lower normative absolute neutrophil counts (ANC), associated with the Duffy null genetic polymorphism. Recent data on clozapine-associated neutropenia in the US are lacking.</p></div><div><h3>Methods</h3><p>Patients prescribed clozapine in the Johns Hopkins Medicine electronic medical record (EMR) between 2013 and 2023 were identified. Duffy null Associated Neutrophil Count (DANC) was assigned if there were two ANC's &lt; 2000 cells/μL, &gt;30 days apart, before starting clozapine. Rates of neutropenia, timing of first neutropenia, and demographic differences were explored.</p></div><div><h3>Results</h3><p>974 received clozapine and had ANC's available, with 63.9 % male, 51.1 % White, and 39 % Black. 287 were presumed to start clozapine during the study period, and were 62.4 % male, 46 % White, and 44.9 % Black. No patients developed severe neutropenia. 59 (6.1 %) developed mild or moderate neutropenia. 19 (6.6 %) new starts had presumed DANC, and none developed neutropenia. 11 of 16 presumed new starts who developed neutropenia did so within eight months. No demographic differences were found between groups for presumed new starts. For non-new starts, where DANC assignment was not possible, Black patients were more likely than White patients to develop neutropenia (OR 3.48, 95 % CI [1.65, 7.73]).</p></div><div><h3>Discussion</h3><p>To our knowledge, this is the first observational study of clozapine-associated neutropenia in the US in the past decade, and it includes a substantial proportion of Black patients. ANC monitoring requirements may be too strict, contributing to clozapine underutilization.</p></div>","PeriodicalId":21417,"journal":{"name":"Schizophrenia Research","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142089626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Harnessing stem cell-based approaches for clinically meaningful discoveries in schizophrenia. 利用基于干细胞的方法,发现对临床有意义的精神分裂症。
IF 3.6 2区 医学 Q1 PSYCHIATRY Pub Date : 2024-08-29 DOI: 10.1016/j.schres.2024.08.006
Paulo Lizano, Rakesh Karmacharya
{"title":"Harnessing stem cell-based approaches for clinically meaningful discoveries in schizophrenia.","authors":"Paulo Lizano, Rakesh Karmacharya","doi":"10.1016/j.schres.2024.08.006","DOIUrl":"https://doi.org/10.1016/j.schres.2024.08.006","url":null,"abstract":"","PeriodicalId":21417,"journal":{"name":"Schizophrenia Research","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142111523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to Markota et al. “Clinical heterogeneity and ECT in patients with clozapine resistant schizophrenia” SCHRES-D-24-00481 对 Markota 等人 "氯氮平耐药精神分裂症患者的临床异质性和电痉挛疗法 "的回应 SCHRES-D-24-00481
IF 3.6 2区 医学 Q1 PSYCHIATRY Pub Date : 2024-08-29 DOI: 10.1016/j.schres.2024.08.003
{"title":"Response to Markota et al. “Clinical heterogeneity and ECT in patients with clozapine resistant schizophrenia” SCHRES-D-24-00481","authors":"","doi":"10.1016/j.schres.2024.08.003","DOIUrl":"10.1016/j.schres.2024.08.003","url":null,"abstract":"","PeriodicalId":21417,"journal":{"name":"Schizophrenia Research","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142099635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pre-stimulus EEG phase coherence predicts visual target detection failures in schizophrenia: A pilot study 刺激前脑电图相位一致性可预测精神分裂症患者的视觉目标检测失败:试点研究
IF 3.6 2区 医学 Q1 PSYCHIATRY Pub Date : 2024-08-29 DOI: 10.1016/j.schres.2024.08.016

Impaired visual target detection is a common finding in schizophrenia that is linked to poor functional outcomes. However, the neural mechanisms that contribute to this deficit remain unclear. Recent research in healthy samples has identified relationships between the phase of pre-stimulus electroencephalographic (EEG) activity in the alpha band (8-12 Hz) or theta band (4-7 Hz) and the likelihood of visual target detection with and without attentional cueing, but these effects have not yet been explored in schizophrenia. We performed a study to investigate such effects in schizophrenia (n = 19) and healthy participants (n = 14), using a visual target detection task with attentional cues. We found significant relationships between pre-stimulus EEG phase properties and visual target detection in both groups, but also clear differences in the effects as a function of frequency, group, and attentional cueing. Alpha-band phase effects were relatively uniform across groups and conditions. By contrast, theta-band phase effects showed differences by group and attentional condition which could be consistent with attentional hyperfocusing in the schizophrenia group. Thus, our results elucidate a novel neural mechanism that may help to explain known impairments affecting both visual target detection and attention in schizophrenia.

视觉目标检测能力受损是精神分裂症患者的常见症状,与不良的功能预后有关。然而,导致这种缺陷的神经机制仍不清楚。最近在健康样本中进行的研究发现,刺激前的α波段(8-12赫兹)或θ波段(4-7赫兹)脑电图(EEG)活动的相位与在有或没有注意线索的情况下视觉目标检测的可能性之间存在关系,但这些影响尚未在精神分裂症中进行探讨。我们对精神分裂症患者(19 人)和健康参与者(14 人)进行了一项研究,利用有注意线索的视觉目标检测任务来调查这种效应。我们发现,在这两组人中,刺激前脑电相位特性与视觉目标检测之间都有明显的关系,但随着频率、组别和注意线索的不同,这种效应也有明显的差异。阿尔法波段相位效应在不同组别和条件下相对一致。相比之下,θ波段相位效应在不同组别和注意条件下表现出差异,这可能与精神分裂症组的注意过度集中一致。因此,我们的研究结果阐明了一种新的神经机制,它可能有助于解释精神分裂症患者视觉目标检测和注意力的已知障碍。
{"title":"Pre-stimulus EEG phase coherence predicts visual target detection failures in schizophrenia: A pilot study","authors":"","doi":"10.1016/j.schres.2024.08.016","DOIUrl":"10.1016/j.schres.2024.08.016","url":null,"abstract":"<div><p>Impaired visual target detection is a common finding in schizophrenia that is linked to poor functional outcomes. However, the neural mechanisms that contribute to this deficit remain unclear. Recent research in healthy samples has identified relationships between the phase of pre-stimulus electroencephalographic (EEG) activity in the alpha band (8-12 Hz) or theta band (4-7 Hz) and the likelihood of visual target detection with and without attentional cueing, but these effects have not yet been explored in schizophrenia. We performed a study to investigate such effects in schizophrenia (<em>n</em> = 19) and healthy participants (<em>n</em> = 14), using a visual target detection task with attentional cues. We found significant relationships between pre-stimulus EEG phase properties and visual target detection in both groups, but also clear differences in the effects as a function of frequency, group, and attentional cueing. Alpha-band phase effects were relatively uniform across groups and conditions. By contrast, theta-band phase effects showed differences by group and attentional condition which could be consistent with attentional hyperfocusing in the schizophrenia group. Thus, our results elucidate a novel neural mechanism that may help to explain known impairments affecting both visual target detection and attention in schizophrenia.</p></div>","PeriodicalId":21417,"journal":{"name":"Schizophrenia Research","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0920996424003876/pdfft?md5=55c6384d370f5e5187eab02ede80379d&pid=1-s2.0-S0920996424003876-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142099633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Examining measures of schizotypy for gender and racial bias using item response theory and differential item functioning 利用项目反应理论和差异项目功能检查精神分裂症测量中的性别和种族偏见
IF 3.6 2区 医学 Q1 PSYCHIATRY Pub Date : 2024-08-29 DOI: 10.1016/j.schres.2024.08.015

Schizotypy involves schizophrenia-like traits and symptoms, with the Wisconsin Schizotypy Scales (WSS) being frequently used in previous research. There is some evidence that schizophrenia-spectrum symptom levels, including when using the WSS, might vary both by gender and by race and ethnicity. However, previous research has rarely examined to what extent the WSS show gender and racial bias. Further, this has not been previously examined for the Cognitive Slippage Scale, a measure of disorganized schizotypy. In this study, we examined biases for a subset of items from the WSS in a large sample of undergraduate students (n = 21,829). Using item response theory to test for levels of differential item functioning (DIF), we found some evidence of problematic DIF for all scales, including for negative, positive, and disorganized schizotypy scales. There was evidence of problematic DIF especially by gender and for Black and Multiracial participants. Overall, the current results suggest that gender and/or racial bias on these scales should be an important consideration in using these scales and our results could have implications for assessment of schizophrenia-spectrum symptoms.

分裂型涉及类似精神分裂症的特征和症状,威斯康星分裂型量表(WSS)是以往研究中经常使用的量表。有证据表明,精神分裂症的症状水平(包括使用威斯康辛分裂型量表时的症状水平)可能会因性别、种族和民族而异。然而,以往的研究很少研究 WSS 在多大程度上显示出性别和种族偏见。此外,认知滑坡量表(Cognitive Slippage Scale)也未对此进行过研究,而该量表是对分裂型人格障碍的一种测量。在本研究中,我们对大量本科生样本(n = 21829)中的 WSS 项目子集进行了偏差检验。通过使用项目反应理论来检验差异项目功能(DIF)的水平,我们发现所有量表都存在一些有问题的 DIF 证据,包括消极、积极和无组织精神分裂症量表。有证据表明,不同性别以及黑人和多种族参与者的 DIF 存在问题。总之,目前的结果表明,在使用这些量表时,性别和/或种族偏差应该是一个重要的考虑因素,我们的结果可能会对精神分裂症谱症状的评估产生影响。
{"title":"Examining measures of schizotypy for gender and racial bias using item response theory and differential item functioning","authors":"","doi":"10.1016/j.schres.2024.08.015","DOIUrl":"10.1016/j.schres.2024.08.015","url":null,"abstract":"<div><p>Schizotypy involves schizophrenia-like traits and symptoms, with the Wisconsin Schizotypy Scales (WSS) being frequently used in previous research. There is some evidence that schizophrenia-spectrum symptom levels, including when using the WSS, might vary both by gender and by race and ethnicity. However, previous research has rarely examined to what extent the WSS show gender and racial bias. Further, this has not been previously examined for the Cognitive Slippage Scale, a measure of disorganized schizotypy. In this study, we examined biases for a subset of items from the WSS in a large sample of undergraduate students (<em>n</em> = 21,829). Using item response theory to test for levels of differential item functioning (DIF), we found some evidence of problematic DIF for all scales, including for negative, positive, and disorganized schizotypy scales. There was evidence of problematic DIF especially by gender and for Black and Multiracial participants. Overall, the current results suggest that gender and/or racial bias on these scales should be an important consideration in using these scales and our results could have implications for assessment of schizophrenia-spectrum symptoms.</p></div>","PeriodicalId":21417,"journal":{"name":"Schizophrenia Research","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142099632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What impact did the COVID-19 pandemic have on psychosis and the delivery of early intervention psychosis services? COVID-19 大流行对精神病和提供早期干预精神病服务有什么影响?
IF 3.6 2区 医学 Q1 PSYCHIATRY Pub Date : 2024-08-28 DOI: 10.1016/j.schres.2024.08.013

Background

In Australia, the first nationwide COVID-19 lockdown occurred in March 2020 bringing challenges for early intervention psychosis (EIP) services. Limited evidence exists on the impacts of the pandemic on treatment outcomes among EIP clients.

Methods

This prospective cohort study analysed routine data from 15 headspace Early Psychosis centres in Australia. Participants were 12 to 25 years, meeting criteria for First Episode Psychosis (FEP) or Ultra High Risk of psychosis (UHR) comparing those who commenced treatment ‘pre-COVID-19’ (between 16th August 2018 and 15th August 2019), and ‘during-COVID-19’ (between 1st March 2020 and 15th September 2020). Clinical symptoms at treatment commencement were assessed using the Brief Psychiatric Rating Scale (BPRS) and the Kessler Psychological Distress Scale (K10). with outcomes after 6 months compared between cohorts using linear mixed-effects regression, controlling for confounders.

Results

Of 1246 young people analysed (653 FEP, 596 UHR), significant improvements were observed with treatment in both groups (5 to 13-point reduction in BPRS score per 6-months treatment). Treatment effectiveness reduced during-COVID-19 for psychosis symptoms, with the FEP BPRS treatment effect lower by 4.3 points (95%CI: 0.5, 8.1). UHR clients had lower BPRS negative symptoms during-COVID-19 (p = 0.020). Service contacts increased during-COVID-19, with increased telehealth services (p < 0.001).

Conclusions

Early intervention remained effective for FEP and UHR, despite the pandemic and transition of EIP services to virtual service delivery. Reduced treatment efficacy in FEP psychosis symptoms may indicate potential limitations of telehealth. Further research to examine longer term clinical and functional outcomes due to the pandemic is required.

背景澳大利亚于 2020 年 3 月首次在全国范围内封锁 COVID-19,这给早期干预精神病(EIP)服务带来了挑战。这项前瞻性队列研究分析了澳大利亚15个早期干预精神病中心的常规数据。参与者年龄在12至25岁之间,符合首发精神病(FEP)或超高风险精神病(UHR)的标准,比较 "COVID-19前"(2018年8月16日至2019年8月15日期间)和 "COVID-19期间"(2020年3月1日至2020年9月15日期间)开始治疗的患者。开始治疗时的临床症状采用简易精神病评定量表(BPRS)和凯斯勒心理压力量表(K10)进行评估。结果在分析的 1246 名年轻人中(653 名 FEP,596 名 UHR),两组的治疗效果都有显著改善(每治疗 6 个月,BPRS 分数降低 5 到 13 分)。在 COVID-19 治疗期间,精神病症状的治疗效果有所下降,联邦教育计划的 BPRS 治疗效果降低了 4.3 分(95%CI:0.5,8.1)。在 COVID-19 期间,UHR 客户的 BPRS 阴性症状较低(p = 0.020)。COVID-19期间,随着远程医疗服务的增加,服务接触也有所增加(p = 0.001)。结论尽管发生了大流行病,EIP服务也过渡到了虚拟服务,但早期干预对FEP和UHR仍然有效。对 FEP 精神病症状的疗效降低可能表明远程医疗存在潜在的局限性。还需要进一步研究大流行对临床和功能产生的长期影响。
{"title":"What impact did the COVID-19 pandemic have on psychosis and the delivery of early intervention psychosis services?","authors":"","doi":"10.1016/j.schres.2024.08.013","DOIUrl":"10.1016/j.schres.2024.08.013","url":null,"abstract":"<div><h3>Background</h3><p>In Australia, the first nationwide COVID-19 lockdown occurred in March 2020 bringing challenges for early intervention psychosis (EIP) services. Limited evidence exists on the impacts of the pandemic on treatment outcomes among EIP clients.</p></div><div><h3>Methods</h3><p>This prospective cohort study analysed routine data from 15 <em>headspace</em> Early Psychosis centres in Australia. Participants were 12 to 25 years, meeting criteria for First Episode Psychosis (FEP) or Ultra High Risk of psychosis (UHR) comparing those who commenced treatment ‘pre-COVID-19’ (between 16th August 2018 and 15th August 2019), and ‘during-COVID-19’ (between 1st March 2020 and 15th September 2020). Clinical symptoms at treatment commencement were assessed using the Brief Psychiatric Rating Scale (BPRS) and the Kessler Psychological Distress Scale (K10). with outcomes after 6 months compared between cohorts using linear mixed-effects regression, controlling for confounders.</p></div><div><h3>Results</h3><p>Of 1246 young people analysed (653 FEP, 596 UHR), significant improvements were observed with treatment in both groups (5 to 13-point reduction in BPRS score per 6-months treatment). Treatment effectiveness reduced during-COVID-19 for psychosis symptoms, with the FEP BPRS treatment effect lower by 4.3 points (95%CI: 0.5, 8.1). UHR clients had lower BPRS negative symptoms during-COVID-19 (<em>p</em> = 0.020). Service contacts increased during-COVID-19, with increased telehealth services (<em>p</em> &lt; 0.001).</p></div><div><h3>Conclusions</h3><p>Early intervention remained effective for FEP and UHR, despite the pandemic and transition of EIP services to virtual service delivery. Reduced treatment efficacy in FEP psychosis symptoms may indicate potential limitations of telehealth. Further research to examine longer term clinical and functional outcomes due to the pandemic is required.</p></div>","PeriodicalId":21417,"journal":{"name":"Schizophrenia Research","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0920996424003840/pdfft?md5=cb3557992f3b8869bff56a3269b19c39&pid=1-s2.0-S0920996424003840-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142089619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Telomere biology and its maintenance in schizophrenia spectrum disorders: Exploring links to cognition 端粒生物学及其在精神分裂症谱系障碍中的维持:探索与认知的联系
IF 3.6 2区 医学 Q1 PSYCHIATRY Pub Date : 2024-08-28 DOI: 10.1016/j.schres.2024.08.011

Objective

Contemporary research suggests reduced telomere length in schizophrenia spectrum disorders (SZ) compared to age-adjusted non-affected individuals. However, the role of telomere maintenance and telomere repair in SZ is poorly understood as well as the involvement of telomere biology in cognitive abnormalities in SZ.

Methods

The study consisted of 758 participants (SZ [n = 357] and healthy controls, HC [n = 401]) collected as part of the Norwegian TOP study. Participants were assessed with standardized neuropsychological tests measuring five cognitive domains. Leucocyte telomere length (TL) was measured via blood and determined by quantitative real-time Polymerase Chain Reaction (qPCR) providing a telomere to single copy ratio (T/S ratio), used to estimate the mean telomere length. Telomerase activity was assessed by the expression levels of the Telomerase Reverse Transcriptase (TERT) and Telomerase RNA Component (TERC) genes. To assess telomere maintenance and telomere repair we calculated the telomerase expression to TL ratio (TERT/TL and TERC/TL respectively).

Results

Patients had reduced TERT (F = 5.03, p = 0.03), but not TERC expression (F = 1.04, p = 0.31), and higher TERT/TL (F = 6.68, p = 0.01) and TERC/TL (F = 6.71, p = 0.01), adjusted for age, sex, and ethnicity. No statistically significant association was observed between any of the telomere biology markers and the cognitive domains (p > 0.05).

Conclusion

Our study shows changes in TERT expression and telomere maintenance and telomere repair in SZ compared HC. However, the role of telomere biology in the mechanism underlying cognitive impairment in psychosis seems limited.

目的当代研究表明,与年龄调整后未受影响的个体相比,精神分裂症谱系障碍(SZ)患者的端粒长度减少。然而,人们对端粒维持和端粒修复在精神分裂症中的作用以及端粒生物学在精神分裂症认知异常中的参与还知之甚少。方法该研究包括挪威TOP研究中收集的758名参与者(精神分裂症[n = 357]和健康对照组[n = 401])。研究人员通过标准化的神经心理学测试对参与者进行了评估,测试内容包括五个认知领域。白细胞端粒长度(TL)通过血液进行测量,并通过定量实时聚合酶链式反应(qPCR)测定端粒与单拷贝比值(T/S比值),用来估算平均端粒长度。端粒酶活性通过端粒酶逆转录酶(TERT)和端粒酶 RNA 成分(TERC)基因的表达水平进行评估。为了评估端粒维持和端粒修复情况,我们计算了端粒酶表达与TL的比率(分别为TERT/TL和TERC/TL)。结果经年龄、性别和种族调整后,患者的TERT表达减少(F = 5.03,p = 0.03),但TERC表达未减少(F = 1.04,p = 0.31),TERT/TL(F = 6.68,p = 0.01)和TERC/TL(F = 6.71,p = 0.01)较高。结论我们的研究表明,与HC相比,SZ的TERT表达、端粒维持和端粒修复发生了变化。然而,端粒生物学在精神病认知障碍的机制中的作用似乎有限。
{"title":"Telomere biology and its maintenance in schizophrenia spectrum disorders: Exploring links to cognition","authors":"","doi":"10.1016/j.schres.2024.08.011","DOIUrl":"10.1016/j.schres.2024.08.011","url":null,"abstract":"<div><h3>Objective</h3><p>Contemporary research suggests reduced telomere length in schizophrenia spectrum disorders (SZ) compared to age-adjusted non-affected individuals. However, the role of telomere maintenance and telomere repair in SZ is poorly understood as well as the involvement of telomere biology in cognitive abnormalities in SZ.</p></div><div><h3>Methods</h3><p>The study consisted of 758 participants (SZ [<em>n</em> = 357] and healthy controls, HC [<em>n</em> = 401]) collected as part of the Norwegian TOP study. Participants were assessed with standardized neuropsychological tests measuring five cognitive domains. Leucocyte telomere length (TL) was measured via blood and determined by quantitative real-time Polymerase Chain Reaction (qPCR) providing a telomere to single copy ratio (T/S ratio), used to estimate the mean telomere length. Telomerase activity was assessed by the expression levels of the Telomerase Reverse Transcriptase (<em>TERT</em>) and Telomerase RNA Component (<em>TERC</em>) genes. To assess telomere maintenance and telomere repair we calculated the telomerase expression to TL ratio (<em>TERT</em>/TL and <em>TERC</em>/TL respectively).</p></div><div><h3>Results</h3><p>Patients had reduced <em>TERT</em> (<em>F</em> = 5.03, <em>p</em> = 0.03), but not <em>TERC</em> expression (<em>F</em> = 1.04, <em>p</em> = 0.31), and higher <em>TERT</em>/TL (<em>F</em> = 6.68, <em>p</em> = 0.01) and <em>TERC</em>/TL (<em>F</em> = 6.71, <em>p</em> = 0.01), adjusted for age, sex, and ethnicity. No statistically significant association was observed between any of the telomere biology markers and the cognitive domains (<em>p</em> &gt; 0.05).</p></div><div><h3>Conclusion</h3><p>Our study shows changes in <em>TERT</em> expression and telomere maintenance and telomere repair in SZ compared HC. However, the role of telomere biology in the mechanism underlying cognitive impairment in psychosis seems limited.</p></div>","PeriodicalId":21417,"journal":{"name":"Schizophrenia Research","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0920996424003827/pdfft?md5=1d24d26af842c38591ff5eaed298916d&pid=1-s2.0-S0920996424003827-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142089625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Schizophrenia Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1